Ventricular Electrocardiographic Intervals (e.g., Q-t Interval) Patents (Class 607/25)
-
Publication number: 20120185012Abstract: Techniques are provided for use with implantable cardiac stimulation devices equipped for multi-site left ventricular (MSLV) cardiac pacing. Briefly, intraventricular and interventricular conduction delays are detected for paced cardiac events. Maximum pacing time delays are determined for use with MSLV pacing where the maximum pacing time delays are set based on the conduction delays to values sufficient to avoid capture problems due to wavefront propagation, such as fusion or lack of capture. MSLV pacing delays are then set to values no greater than the maximum pacing delays and cardiac resynchronization therapy (CRT) is delivered using the MSLV pacing delays. In an example where an optimal interventricular pacing delay (VV) is determined in advance using intracardiac electrogram-based or hemodynamic-based optimization techniques, the optimal value for VV can be used as a limiting factor when determining the maximum MSLV pacing time delays.Type: ApplicationFiled: January 19, 2011Publication date: July 19, 2012Applicant: PACESETTER, INC.Inventors: Kyungmoo Ryu, Allen Keel, Heidi Hellman, Tomas Svensson
-
Patent number: 8214041Abstract: This document provides a simple and automatic method for determining an optimal AV interval and/or range of AV intervals for, in an exemplary embodiment, LV-only pacing. Such a method provides significant advantages for patients while reducing burdens related to post-implant follow-up by clinicians in that it greatly reduces the need for doing echocardiographic-based AV interval optimization procedures as well as providing a way to dynamically optimize AV intervals as the patient moves about their activities of daily living (ADL).Type: GrantFiled: April 19, 2005Date of Patent: July 3, 2012Assignee: Medtronic, Inc.Inventors: Berry M. Van Gelder, M. S. J. Pilmeyer, John E Burnes
-
Publication number: 20120165890Abstract: Techniques are provided for use with implantable medical devices such as pacemakers for optimizing interventricular (VV) pacing delays for use with cardiac resynchronization therapy (CRT). In one example, ventricular electrical depolarization events are detected within a patient in which the device is implanted. The onset of isovolumic ventricular mechanical contraction is also detected based on cardiomechanical signals detected by the device, such as cardiogenic impedance (Z) signals, S1 heart sounds or left atrial pressure (LAP) signals. Then, an electromechanical time delay (T_QtoVC) between ventricular electrical depolarization and the onset of isovolumic ventricular mechanical contraction is determined. VV pacing delays are set to minimize the time delay to the onset of isovolumic ventricular mechanical contraction. Various techniques for identifying the onset of isovolumic ventricular contraction based on Z, S1 or LAP or other cardiomechanical signals are described.Type: ApplicationFiled: December 22, 2010Publication date: June 28, 2012Applicant: PACESETTER, INC.Inventor: Xiaoyi Min
-
Publication number: 20120165891Abstract: A device and method for delivering electrical stimulation to the heart in order to improve cardiac function in heart failure patients. The stimulation is delivered as high-output pacing in which the stimulation is excitatory and also of sufficient energy to augment myocardial contractility. In order to provide a consistent hemodynamic response, the high-output pacing is optimized by delivering it using different parameter sets, evaluating the hemodynamic response thereto as reflected by one or more measured physiological variables, and selecting the parameter set with the best hemodynamic response.Type: ApplicationFiled: March 5, 2012Publication date: June 28, 2012Inventors: Shantha Arcot-Krishnamurthy, Allan C. Shuros, Christopher Hartemink
-
Publication number: 20120165892Abstract: Systems and methods are provided wherein intracardiac electrogram (IEGM) signals are used to determine a set of preliminary optimized atrioventricular (AV/PV) and interventricular (VV) pacing delays. In one example, the preliminary optimized AV/VV pacing delays are used as a starting point for further optimization based on impedance signals such as impedance signals detected between a superior vena cava (SVC) coil electrode and a device housing electrode, which are influenced by changes in stroke volume within the patient. Ventricular pacing is thereafter delivered using the AV/VV pacing delays optimized via impedance. In another example, parameters derived from IEGM signals are used to limit the scope of an impedance-based optimization search to reduce the number of pacing tests needed during impedance-based optimization. Biventricular and multi-site left ventricular (MSLV) examples are described.Type: ApplicationFiled: December 22, 2010Publication date: June 28, 2012Applicant: PACESETTER, INC.Inventors: Xiaoyi Min, Gene A. Bornzin, Martin Cholette, Kyungmoo Ryu, Catherine Tan
-
Publication number: 20120165896Abstract: A pacing mode is provided, in one embodiment, that permits missed or skipped ventricular beats. The mode monitors a full cardiac cycle (A-A interval) for the presence of intrinsic ventricular activity. If ventricular activity is present, a flag is set that is valid for the next cardiac cycle. At the beginning of the next cardiac cycle, the device determines if the flag is present. So long as the flag is present, the device will not deliver a ventricular pacing pulse in that cycle, even if there is no intrinsic ventricular activity. If there is no flag present at the start of a given cardiac cycle, a ventricular pacing pulse is delivered and this ventricular activity sets a flag for the subsequent cardiac cycle.Type: ApplicationFiled: March 5, 2012Publication date: June 28, 2012Applicant: Medtronic, Inc.Inventor: John C. Stroebel
-
Publication number: 20120165895Abstract: Cardiac devices and methods discriminate non-captured intrinsic beats during evoked response detection and classification by comparing the features of a post-pace cardiac signal with expected features associated with a non-captured response with intrinsic activation. Detection of a non-captured response with intrinsic activation may be based on the peak amplitude and timing of the cardiac signal. The methods may be used to discriminate between a fusion or capture beat and a non-captured intrinsic beat. Discriminating between possible cardiac responses to the pacing pulse may be useful, for example, during automatic capture verification and/or a capture threshold test.Type: ApplicationFiled: March 5, 2012Publication date: June 28, 2012Applicant: CARDIAC PACEMAKERS, INC.Inventors: Yanting Dong, Scott A. Meyer, Kevin John Stalsberg
-
Publication number: 20120165894Abstract: This document discusses, among other things, systems, devices, and methods measure an impedance and, in response, adjust an atrioventricular (AV) delay or other cardiac resynchronization therapy (CRT) parameter that synchronizes left and right ventricular contractions. A first example uses parameterizes a first ventricular volume against a second ventricular volume during a cardiac cycle, using a loop area to create a synchronization fraction (SF). The CRT parameter is adjusted in closed-loop fashion to increase the SF. A second example measures a septal-freewall phase difference (PD), and adjusts a CRT parameter to decrease the PD. A third example measures a peak-to-peak volume or maximum rate of change in ventricular volume, and adjusts a CRT parameter to increase the peak-to-peak volume or maximum rate of change in the ventricular volume.Type: ApplicationFiled: February 27, 2012Publication date: June 28, 2012Inventors: Jiang Ding, Julio C. Spinelli, Yinghong Yu, Jeffrey E. Stahmann
-
Publication number: 20120165893Abstract: A pacing system computes optimal cardiac resynchronization pacing parameters using intrinsic conduction intervals. In various embodiments, values for atrio-ventricular delay intervals are each computed as a function of an intrinsic atrio-ventricular interval and a parameter reflective of an interventricular conduction delay. Examples of the parameter reflective of the interventricular conduction delay include QRS width and interval between right and left ventricular senses.Type: ApplicationFiled: February 16, 2012Publication date: June 28, 2012Inventors: Jiang Ding, Yinghong Yu, Milton M. Morris
-
Publication number: 20120158087Abstract: A refractory period for a pacemaker sensing channel refers to a period of time during which the sensing channel is either blind to incoming electrical signals, termed a blanking interval, and/or during which the device is configured to ignore such signals for purposes of sense event detection. Methods and devices for implementing refractory periods in the context of multi-site left ventricular pacing are described.Type: ApplicationFiled: December 15, 2011Publication date: June 21, 2012Inventors: Jeffrey E. Stahmann, James O. Gilkerson, Krzysztof Z. Siejko, James Kalgren
-
Publication number: 20120158088Abstract: A method and system are disclosed for setting the pacing parameters utilized by an implantable cardiac device in delivering cardiac resynchronization therapy. The system may, in different embodiments, be implemented in programming of the implantable device and an external programmer in communication therewith or in the programming of the implantable device by itself. The selection of the pacing parameters is based at least in part upon measurements of intrinsic cardiac conduction parameters. Among the pacing parameters which may be selected in this way are the atrio-ventricular delay interval used in atrial-tracking and AV sequential pacing modes and the biventricular offset interval.Type: ApplicationFiled: February 27, 2012Publication date: June 21, 2012Inventors: Andrew P. Kramer, Jiang Ding
-
Publication number: 20120150253Abstract: Methods and devices for determining optimal Atrial to Ventricular (AV) pacing intervals and Ventricular to Ventricular (VV) delay intervals in order to optimize cardiac output. Impedance, preferably sub-threshold impedance, is measured across the heart at selected cardiac cycle times as a measure of chamber expansion or contraction. One embodiment measures impedance over a long AV interval to obtain the minimum impedance, indicative of maximum ventricular expansion, in order to set the AV interval. Another embodiment measures impedance change over a cycle and varies the AV pace interval in a binary search to converge on the AV interval causing maximum impedance change indicative of maximum ventricular output. Another method varies the right ventricle to left ventricle (VV) interval to converge on an impedance maximum indicative of minimum cardiac volume at end systole. Another embodiment varies the VV interval to maximize impedance change.Type: ApplicationFiled: February 20, 2012Publication date: June 14, 2012Applicant: Medtronic, Inc.Inventors: John E. Burnes, Yong K. Cho, David Igel, Luc R. Mongeon, John C. Rueter, Harry Stone, Jodi Zilinski
-
Publication number: 20120150254Abstract: An atrial event and a ventricular event can be received, and an atrioventricular (AV) delay can be provided using information about the atrial and ventricular events. The AV delay can be increased after a first condition is satisfied to allow a heart to regain intrinsic control of ventricular activation, and changed after a second condition is satisfied to allow the heart to remain in intrinsic control of ventricular activation.Type: ApplicationFiled: February 22, 2012Publication date: June 14, 2012Inventors: David L. Perschbacher, Richard Milon Dujmovic, JR., Gary T. Seim
-
Publication number: 20120143277Abstract: A cardiac rhythm management system selects one of multiple electrodes associated with a particular heart chamber based on a relative timing between detection of a depolarization fiducial point at the multiple electrodes, or based on a delay between detection of a depolarization fiducial point at the multiple electrodes and detection of a reference depolarization fiducial point at another electrode associated with the same or a different heart chamber. Subsequent contraction-evoking stimulation therapy is delivered from the selected electrode.Type: ApplicationFiled: February 8, 2012Publication date: June 7, 2012Inventors: Jiang Ding, Julio C. Spinelli, Andrew P. Kramer
-
Publication number: 20120136406Abstract: Techniques are provided for use with implantable medical devices such as pacemakers for optimizing atrioventricular (AV) pacing delays for use with cardiac resynchronization therapy (CRT). In one example, the end of atrial mechanical contraction and the onset of isovolumic ventricular mechanical contraction are detected within a patient in which the device is implanted based on cardiomechanical signals, such as cardiogenic impedance (Z) signals, S1 heart sounds or left atrial pressure (LAP) signals. Then, a cardiomechanical time delay (MC_AV) between the end of atrial contraction and the onset of isovolumic ventricular contraction is determined. AV pacing delays are set based on MC_AV to align the end an atrial kick with the onset of isovolumic ventricular contraction. Thereafter, pacing is controlled based on the AV pacing delays.Type: ApplicationFiled: November 30, 2010Publication date: May 31, 2012Applicant: PACESETTER, INC.Inventor: Xiaoyi Min
-
Publication number: 20120130442Abstract: Cardiac anodal electrostimulation detection systems and methods are described, such as for distinguishing between cathodal-only capture and at least partially anodal capture (e.g., combined anodal and cathodal capture, or between two anodes of which only one captures nearby cardiac tissue, etc.).Type: ApplicationFiled: November 21, 2011Publication date: May 24, 2012Inventors: Holly Rockweiler, Shibaji Shome, Aaron R. McCabe, Rachel A. Taylor
-
Publication number: 20120130440Abstract: An apparatus comprises an implantable cardiac signal sensing circuit that provides an electrical cardiac signal representative of cardiac activity of a subject, an implantable therapy circuit that delivers electrical pacing stimulation energy to a heart of a subject, and a controller circuit. The controller circuit includes a chronotropic incompetence detection circuit that initiates pacing of an atrium of the subject at a rate higher than a device-indicated rate or a sensed intrinsic rate, monitor the AV interval, initiates an increase in the pacing rate while continuing the monitoring of the AV interval, calculates a change in AV intervals between a highest paced rate used in the monitoring and a lowest paced rate used in the monitoring, and indicates that the AV intervals are evidence of chronotropic incompetence when the calculated change in the AV intervals exceeds a specified threshold AV interval change value.Type: ApplicationFiled: November 7, 2011Publication date: May 24, 2012Inventors: Yinghong Yu, Donald L. Hopper, Jiang Ding, James O. Gilkerson
-
Publication number: 20120130443Abstract: Methods and systems to modulate timing intervals for pacing therapy are described. For each cardiac cycle, one or both of an atrioventricular (A-V) timing interval and an atrial (A-A) timing interval are modulated to oppose beat-to-beat ventricular (V-V) timing variability. Pacing therapy is delivered using the modulated timing intervals.Type: ApplicationFiled: January 24, 2012Publication date: May 24, 2012Inventors: Donald L. HOPPER, Yinghong YU, Allan Charles SHUROS, Shantha ARCOT-KRISHNAMURTHY, Gerrard M. CARLSON, Jeffrey STAHMANN
-
Publication number: 20120116473Abstract: An exemplary method includes delivering a cardiac pacing therapy that includes an atrio-ventricular delay and an interventricular delay, providing a paced propagation delay associated with delivery of a stimulus to a ventricle, delivering a stimulus to the ventricle, sensing an event in the other ventricle caused by the stimulus, determining an interventricular conduction delay value based on the delivering and the sensing, determining a interventricular delay (?Sur) based on the interventricular conduction delay and the paced propagation delay and determining an atrio-ventricular delay based at least in part on the interventricular delay (?Sur). Other exemplary methods, devices, systems, etc., are also disclosed.Type: ApplicationFiled: January 17, 2012Publication date: May 10, 2012Applicant: PACESETTER, INC.Inventor: Xiaoyi Min
-
Patent number: 8175708Abstract: Systems and methods are provided for use by an implantable medical device capable of automatically adjusting the sensitivity with which electrical cardiac signals are sensed within a patient, i.e. a device equipped with Automatic Sensitivity Control (ASC.) In a first example, ASC parameters are automatically adjusted by the device itself based on parameters derived from both R-waves and T-waves and further based on a detected noise floor. In a second example, a profile representative of the shape of cardiac signals is generated by the device. ASC parameters are then adjusted based on the profile. In various embodiments, histograms are used to determine sizes and shapes of the R-waves and T-waves via statistical prevalence techniques. The histograms are also employed to derive the aforementioned profile.Type: GrantFiled: December 7, 2006Date of Patent: May 8, 2012Assignee: Pacesetter, Inc.Inventors: Jeffery D. Snell, Rupinder Bharmi
-
Publication number: 20120109245Abstract: Methods and/or devices are disclosed herein for monitoring cardiac impedance signal and delivering therapy to a patient's heart based upon the monitored cardiac impedance.Type: ApplicationFiled: October 29, 2010Publication date: May 3, 2012Inventors: Douglas A. Hettrick, Todd M. Zielinski, Eduardo Warman, Shantanu Sarkar
-
Patent number: 8170653Abstract: A system for the detection of cardiac events occurring in a human patient is provided. At least two electrodes are included in the system for obtaining an electrical signal from a patient's heart. An electrical signal processor is electrically coupled to the electrodes for processing the electrical signal and a patient alarm means is further provided and electrically coupled to the electrical signal processor. The electrical signal is acquired in the form of electrogram segments, which are categorized according to heart rate, ST segment shift and type heart rhythm (normal or abnormal). Baseline electrogram segments are tracked over time.Type: GrantFiled: February 6, 2009Date of Patent: May 1, 2012Assignee: Angel Medical Systems, Inc.Inventors: David R. Fischell, Jonathan Harwood, Steven R. Johnson, David Keenan
-
Publication number: 20120101542Abstract: An A-H delay can be specified, such as by computing the A-H delay using a measured cardiovascular physiologic parameter. The A-H delay can be used for specifying timing between a paced or sensed atrial contraction and a His-bundle pacing time.Type: ApplicationFiled: October 20, 2011Publication date: April 26, 2012Inventors: Shantha Arcot-Krishnamurthy, Allan C. Shuros, Jiang Ding
-
Publication number: 20120101539Abstract: A pacing output circuit can be configured to generate a ventricular pacing signal configured to be delivered to an electrode near the His bundle in a right ventricle of a heart to pace the right and left ventricles and improve synchronization of at least one of the ventricles relative to intrinsic activity. In an example, the ventricular pacing signal can include first and second signal components in opposite polarity from each other with respect to a reference component, the first and second signal components having substantially identical duration and magnitude.Type: ApplicationFiled: December 18, 2009Publication date: April 26, 2012Inventors: Qingsheng Zhu, Daniel Felipe Ortega, Julio Cesar Spinelli
-
Patent number: 8160700Abstract: An exemplary method includes delivering a cardiac pacing therapy using an electrode configuration for left ventricular, single site pacing or left ventricular, multi-site pacing, measuring a series of interventricular conduction delays using the left ventricular pacing and right ventricular sensing (IVCD-LR), comparing the interventricular conduction delay values to a limit and, based on the comparison, deciding whether to change the electrode configuration for the left ventricular pacing. Other exemplary methods, devices, systems, etc., are also disclosed.Type: GrantFiled: May 16, 2007Date of Patent: April 17, 2012Assignee: Pacesetter, Inc.Inventors: Kyungmoo Ryu, Jong Gill
-
Publication number: 20120083854Abstract: A medical device programmer and a method of operation in which a first data value is received and used in the execution of one or more algorithms. One or more suggested pulse generator settings are calculated from the one or more algorithms based on the first data value, and the one or more suggested pulse generator settings are displayed on an interactive display screen of the medical device programmer. In one embodiment, the first data value is a duration interval of a QRS complex. From the duration interval, suggestions are made as to one or more ventricular chambers in which to provide pacing pulses. Additionally, pacing intervals for an AV delay are suggested based on measured P-R intervals, or pacing intervals for an LV offset are suggested based on a measured duration interval of a V-V-interval between a right ventricular event and a left ventricular event.Type: ApplicationFiled: December 15, 2011Publication date: April 5, 2012Inventors: Par Lindh, James Kalgren, Jeffrey E. Stahmann, Rene H. Wentkowski
-
Patent number: 8145309Abstract: Implantable systems, and methods for use therein, perform at least one of a cardiac assessment and an autonomic assessment. Short-term fluctuations in PR intervals, that follow the premature contractions in the ventricles, are monitored. At least one of a cardiac assessment and an autonomic assessment is performed based on the monitored fluctuations in PR intervals that follow the premature contractions in the ventricles. This can include assessing a patient's risk of sudden cardiac death (SCD), assessing a patient's autonomic tone and/or detecting myocardial ischemic events based on the monitored fluctuations in PR intervals that follow the premature contractions in the ventricles.Type: GrantFiled: February 26, 2010Date of Patent: March 27, 2012Assignee: Pacesetter, Inc.Inventors: Taraneh Ghaffari Farazi, Euljoon Park
-
Patent number: 8145308Abstract: A medical device and method for determining a parameter for delivery of a predetermined pacing therapy that includes a plurality of electrodes to deliver a pacing therapy, including the predetermined pacing therapy, and a control unit to control the timing of the delivery of the pacing therapy, including the predetermined pacing therapy, by the electrodes. A processor generates a first template in response to the pacing therapy being delivered to only one of a right ventricle and a left ventricle, and a second template in response to the pacing therapy being delivered to only the other of the right ventricle and the left ventricle, and determines the parameter in response to a comparing of subsequently delivered pacing therapy to the first template and the second template.Type: GrantFiled: March 13, 2008Date of Patent: March 27, 2012Assignee: Medtronic, Inc.Inventors: Aleksandre T Sambelashvili, Thomas J Mullen, Jeffrey M. Gillberg
-
Publication number: 20120071944Abstract: In general, the disclosure is directed to techniques for identification and remediation of oversensed cardiac events using far-field electrograms (FFEGMs). Identification of oversensed cardiac events can be used in an ICD to prevent ventricular fibrillation (VF) detection, and thereby avoid delivery of an unnecessary defibrillation shock. Alternatively, or additionally, identification of oversensed cardiac events can be used in an ICD to support delivery of bradycardia pacing during an oversensing condition. In some cases, bradycardia pacing delivered in response to detection of oversensed cardiac events may include pacing pulses from multiple vectors to provide redundancy in the event the oversensing may be due to a lead-related condition.Type: ApplicationFiled: November 21, 2011Publication date: March 22, 2012Applicant: MEDTRONIC, INC.Inventors: Bruce D. Gunderson, Donald James Ruzin
-
Publication number: 20120053651Abstract: Various systems, methods and arrangements are implemented in connection with ventricular pacing. One such method relates to a method for use in connection with ventricular pacing of a left ventricle of a heart from a pacing lead located in the right ventricle. Ventricular function of the heart is sensed. The sensed ventricular function is used to determine whether a conduction abnormality exists. The ventricular pacing is provided in response to determining a conduction abnormality exists and the ventricular pacing is inhibited in response to determining a conduction abnormality does not exist.Type: ApplicationFiled: August 24, 2011Publication date: March 1, 2012Inventors: Qingsheng Zhu, Daniel Felipe Ortega
-
Publication number: 20120046559Abstract: A first chamber minute ventilation rate is determined based on a first transthoracic impedance signal received from a first chamber of a heart and a second chamber minute ventilation rate is determined based on a second transthoracic impedance signal received from a second chamber of the heart. A processor compares the minute ventilation rates to determine a rate. In one embodiment, an accelerometer sensor provides data for evaluating propriety of a rate. Before implementing a rate change, signals from multiple sensors are cross-checked.Type: ApplicationFiled: October 31, 2011Publication date: February 23, 2012Inventor: Scott Freeberg
-
Patent number: 8116867Abstract: The present invention, in illustrative embodiments, includes methods and devices for analyzing cardiac signals in an implantable cardiac stimulus system. Within the analysis, a threshold may be defined related to a cardiac event rate. If the cardiac event rate does not exceed the threshold, filtering of captured cardiac signals occurs, including attenuating T-waves. If the cardiac event rate does exceed the threshold, circuitry for analog filtering or programming for digital filtering is bypassed to avoid attenuating low frequency components of the captured cardiac signals.Type: GrantFiled: August 4, 2005Date of Patent: February 14, 2012Assignee: Cameron Health, Inc.Inventor: Alan H. Ostroff
-
Patent number: 8116859Abstract: Electrocardiologic device for assisted diagnosis, preferably for the diagnosis of Brugada syndrome or Early Repolarization syndrome. This device allows characterizing the ventricular repolarization wave of an ECG signal collected from a patient. Extracting out of the ECG signal, for each heart beat, an ST segment is constituted of a succession of samples of the ventricular repolarization wave, taken within a time window ([QON+80 ms, QON+140 ms]) of a predetermined duration spreading from a moment of window onset defined by a time offset applied to a predetermined temporal origin given by the moment (QON) of appearance of the QRS complex, whose time position is determined on the ECG signal for each heart beat. Quantizing computes an elevation index compared to a predetermined reference level (BL), and analyzing over a succession of heart beats the persistence and/or variation of this elevation index.Type: GrantFiled: October 21, 2008Date of Patent: February 14, 2012Assignee: ELA Medical S.A.S.Inventors: Pierre Maison-Blanche, Fabrice Extramiana
-
Patent number: 8108037Abstract: Methods and systems may identify a vector or a vector configuration, such as a combination of electrodes, for monitoring ischemia. The method may include: selecting a first combination of sensors as a first candidate to be used for monitoring ischemia; detecting a shift in a ST segment of one of an electrocardiogram and a cardiac electrogram using the first candidate; selecting a second combination of sensors as a second candidate to be used for monitoring ischemia; detecting a shift in a ST segment of one of an electrocardiogram and a cardiac electrogram using the second candidate; comparing the ST shifts for the first and second candidates; and identifying one of the first and second candidates for monitoring ischemia based on the comparison. A multi-electrode implantable cardiac device may include a controller configured to effectuate such functions.Type: GrantFiled: July 12, 2010Date of Patent: January 31, 2012Assignee: Pacesetter, Inc.Inventors: Harish Krishnaswamy, Anil Keni
-
Publication number: 20120010516Abstract: A set of cardiogenic impedance signals are detected along different sensing vectors passing through the heart of the patient, particularly vectors passing through the ventricular myocardium. A measure of mechanical dyssynchrony is detected based on differences, if any, among the cardiogenic impedance signals detected along the different vectors. In particular, differences in peak magnitude delay times, peak velocity delay times, peak magnitudes, and waveform integrals of the cardiogenic impedance signals are quantified and compared to detect abnormally contracting segments, if any, within the heart of the patient. Warnings are generated upon detection of any significant increase in mechanical dyssynchrony. Diagnostic information is recorded for clinical review. Pacing therapies such as cardiac resynchronization therapy (CRT) can be activated or controlled in response to mechanical dyssynchrony to improve the hemodynamic output of the heart.Type: ApplicationFiled: September 2, 2011Publication date: January 12, 2012Applicant: PACESETTER, INC.Inventor: Martin Cholette
-
Publication number: 20120004698Abstract: Physiologic demand driven pacing can be used to maintain cardiac synchrony and improve hemodynamic function in patients with heart failure.Type: ApplicationFiled: June 16, 2011Publication date: January 5, 2012Inventors: Donald L. Hopper, Yinghong Yu, David J. Ternes
-
Publication number: 20120004697Abstract: A non-linear dynamic specified AV delay can be used, such as to help maintain cardiac resynchronization therapy, such as in patients with one or more symptoms of congestive heart failure.Type: ApplicationFiled: June 7, 2011Publication date: January 5, 2012Inventors: David J. Ternes, Donald L. Hopper, Yinghong Yu
-
Publication number: 20120004695Abstract: A device comprises a cardiac contraction sensing circuit, a timer circuit, an electrical stimulation circuit, and a controller. The timer circuit provides a time duration of an atrial-atrial interval between successive atrial contractions, a ventricular-ventricular interval between successive ventricular contractions, and an atrial-ventricular (A-V) interval between an atrial contraction and a same cardiac cycle ventricular contraction. The controller includes an event detection module and a pacing module. The event detection module is configured for determining whether A-V block events are sustained over multiple cardiac cycles. The pacing module is configured for providing pacing therapy according to a primary pacing mode that includes AAI(R) mode with non-tracking VVI backup mode, and for switching the pacing therapy to a secondary tracking pacing mode if A-V block events are sustained over multiple cardiac cycles.Type: ApplicationFiled: September 16, 2011Publication date: January 5, 2012Inventor: Gary T. Seim
-
Patent number: 8090444Abstract: An exemplary method includes delivering stimulation energy via a right ventricular site; sensing an evoked response caused by the delivered stimulation energy at the right ventricular site; calculating a paced propagation delay for the right ventricular site (PPDRV); delivering stimulation energy via a left ventricular site; sensing an evoked response caused by the delivered stimulation energy at the left ventricular site; calculating a paced propagation delay for the left ventricular site (PPDLV); and determining an interventricular delay time (VV) for delivery of a bi-ventricular pacing therapy based in part on the paced propagation delay for the right ventricular site (PPDRV) and the paced propagation delay for the left ventricular site (PPDLV). Other exemplary methods, devices, systems, etc., are also disclosed.Type: GrantFiled: November 7, 2008Date of Patent: January 3, 2012Assignee: Pacesetter, Inc.Inventors: Xiaoyi Min, Stuart O. Schecter
-
Publication number: 20110319956Abstract: Disclosed are certain methods, apparatus, and processor-readable mediums that may be used to treat a conduction abnormality of the heart. In one example, the apparatus includes an implantable pacing profile generator configured to generate a specified pacing electrostimulation profile for delivery to a heart via electrodes located near a septal region of the right ventricle of the heart near the His bundle, the pacing profile including a first pulse for delivery via a first electrode; and a second pulse for delivery via a second electrode; and wherein the first and second pulses are at least partially concurrent in time and opposite in polarity to each other.Type: ApplicationFiled: September 1, 2011Publication date: December 29, 2011Inventors: Qingsheng Zhu, Daniel Felipe Ortega
-
Publication number: 20110319776Abstract: Systems and methods for cardiac contraction detection using information indicative of lead motion are described. In an example, an implantable medical device can include a receiver circuit configured to be electrically coupled to conductor comprising a portion of an implantable lead and be configured to obtain information indicative of a movement of the implantable lead due at least in part to a motion of a heart. The device can include a processor circuit configured to determine whether a cardiac mechanical contraction occurred during a specified interval included in the obtained information indicative of the movement of the implantable lead. The processor circuit can be configured to determine information about the cardiac mechanical contraction using the obtained information indicative of the movement of the implantable lead.Type: ApplicationFiled: June 24, 2011Publication date: December 29, 2011Inventors: Robert J. Sweeney, Allan C. Shuros, Krzysztof Z. Siejko, David C. Olson, Frank Ingle
-
Patent number: 8086308Abstract: An implantable medical device is provided that comprises a pulse generator that provides atrial and ventricular pacing pulses on demand. The pulse generator times delivery of the ventricular pacing pulses based on an AV pacing interval. The device also includes an AV hysteresis module that extends the AV interval from a base AV interval to an extended AV interval to promote intrinsic heart activity. A refractory module establishes a PVARP interval equal to base PVARP interval following at least one of the ventricular pacing pulses. The refractory module lengthens the PVARP interval by adding a PVARP extension to a base PVARP interval to provide an extended PVARP interval.Type: GrantFiled: June 23, 2008Date of Patent: December 27, 2011Assignee: Pacesetter, Inc.Inventor: Paul A. Levine
-
Publication number: 20110307026Abstract: Various systems, methods, devices and arrangements are implemented for use in pacing of the heart. One implementation is directed to methods and systems for determining a pacing location in the right ventricle of a heart and near the His bundle. A pacing signal is delivered to the location in the right ventricle. The pacing signal produces a capture of a left ventricle. Properties of the capture are monitored. Results of the monitored capture are used to assess the effectiveness of the delivered pacing signal as a function of heart function. The heart function can be, for example, at least one of a QRS width, fractionation and a timing of electrical stimulation of a late activation site of a left ventricle relative to the QRS.Type: ApplicationFiled: August 25, 2011Publication date: December 15, 2011Inventors: Qingsheng Zhu, Daniel Felipe Ortega
-
Publication number: 20110301661Abstract: A system and method provide for detecting atrial arrhythmias within an implantable medical device capable of sensing and pacing at least an atrium of a heart. Arrhythmia of the atrium is detected. In response to detecting atrial arrhythmia, delivery of pacing signals to the atrium is inhibited under certain conditions. While delivery of the pacing signals to the atrium is inhibited, the detected arrhythmia of the atrium is confirmed during a period of further evaluation. Delivery of pacing signals to the atrium is enabled upon ceasing of the atrial arrhythmia. Inhibiting delivery of the pacing signals during atrial arrhythmia evaluation advantageously provides for an increase in the rate at which the detected arrhythmia is confirmed.Type: ApplicationFiled: August 16, 2011Publication date: December 8, 2011Inventors: Gary Seim, David Perschbacher
-
Patent number: 8073540Abstract: An implantable heart stimulating device has a stimulation pulse generator that emits stimulation pulses at an adjustable stimulation rate, an activity sensor that emits an activity signal in response to detected activity of the patient, and a physiological parameter sensor that generates a physiological sensor signal in response to a detected physiological parameter. The activity and physiological sensor signals are supplied to a control arrangement that sets the stimulation rate for the stimulation pulse generator by executing a stimulation rate algorithm dependent on those signals. In the stimulation rate algorithm, if the physiological signal indicates an emotional stress on the part of the patient, the stimulation rate is increased to an adjustable emotional stress rate level, and if no increase in the activity signal occurs during a predetermined time period following the stimulation rate increase, the stimulation rate is decreased.Type: GrantFiled: June 21, 2006Date of Patent: December 6, 2011Assignee: St. Jude Medical ABInventors: Kjell Norén, Kenth Nilsson
-
Publication number: 20110276105Abstract: Various approaches are described for managing refractory periods based on the detection of an evoked response. The heart is paced and an evoked response is detected. At least one refractory period is adapted based on the detected evoked response. Adapting the refractory period may involve, for example, initiating a refractory period, terminating a refractory period, extending a refractory period or modifying one or more parameters of the refractory period. Adapting the refractory period may involve modifying a sensing threshold based on the detected evoked response. The sensing threshold of an atrial sensing channel may be adjusted, for example, to avoid sensing a ventricular evoked response on the atrial channel while allowing sensing of a P-wave on the atrial channel.Type: ApplicationFiled: July 19, 2011Publication date: November 10, 2011Inventor: Harley White
-
Publication number: 20110264159Abstract: The invention is directed to methods and devices for optimization of biventricular pacing in subjects suffering from heart failure. The invention provides for a method for selection of optimal parameters for permanent pacing, the method comprising: positioning one or more arrays of lead wires in the posterior pericardium of a subject, wherein the arrays are connected to a multiplexing switch, wherein the switch is connected to a computer processor and a biventricular pacemaker, from the computer processor, generating a randomized sequence of: (i) pacing sites (VPS), (ii) right ventricular-left ventricular delays (RLDs), (iii) heart rates (HR); (iv) atrioventricular delays (AVDs), (v) or any combination or permutation thereof; and determining cardiac output in real time, using aortic flow velocity, thereby allowing selection of optimal parameters for permanent pacing.Type: ApplicationFiled: April 4, 2006Publication date: October 27, 2011Applicant: The Trustees of Columbia in the City of New YorkInventors: Henry M. Spotnitz, Thomas A. Quinn, George Berberian
-
Patent number: 8046063Abstract: An implantable medical device operates with an algorithm that promotes intrinsic conduction and reduces ventricular pacing. The IMD monitors the occurrence of necessary ventricular pacing and takes certain actions based upon whether this occurrence has been relatively high or relatively low. When noise is detected, asynchronous pacing is provided when the occurrence is relatively high and is not provided when relatively low. When atrial threshold testing is performed, the incidence will determine which methodology is utilized.Type: GrantFiled: February 28, 2006Date of Patent: October 25, 2011Assignee: Medtronic, Inc.Inventor: Robert A. Betzold
-
Patent number: 8046066Abstract: An apparatus for reversing ventricular remodeling with electro-stimulatory therapy. A ventricle is paced by delivering one or more stimulatory pulses in a manner such that a stressed region of the myocardium is pre-excited relative to other regions in order to subject the stressed region to a lessened preload and afterload during systole. The unloading of the stressed myocardium over time effects reversal of undesirable ventricular remodeling.Type: GrantFiled: June 15, 2009Date of Patent: October 25, 2011Assignee: Cardiac Pacemakers, Inc.Inventors: Andrew P. Kramer, Rodney W. Salo, Julio C. Spinelli, Bruce H. KenKnight
-
Publication number: 20110257697Abstract: In an implantable medical device and a method for monitoring ventricular synchronicity of a heart. In particular, impedance signals are measured and an occurrence of a notch is detected in the impedance signal coincident with a period including a change from rapid to slow filling of a ventricle. The notch is indicated by a first positive slope change in a negative slope in a predetermined time window during a diastolic phase of a cardiac cycle. A degree of synchronicity is determined based on the notch feature, wherein a decreasing notch feature indicates an increased degree of synchronicity in the filling phase of the ventricles.Type: ApplicationFiled: December 22, 2008Publication date: October 20, 2011Inventor: Karin Jarverud